Pharmaceutical Executives Testimony on Drug Pricing, Day 2
Amgen CEO Robert Bradway, Novartis U.S. Country President Thomas Kendris, and Mallinckrodt Pharmaceuticals CEO Mark Trudeau testified on prescription drug pricing before the House Oversight …
1,878 views